Photo by nci from unsplash
e18094Background: Anti-angiogenic TKI is the most potential effective strategy for patients (pts) with progressive radioiodine refractory differentiated thyroid cancer (RAIR-DTC). This phase II tri... Click to show full abstract
e18094Background: Anti-angiogenic TKI is the most potential effective strategy for patients (pts) with progressive radioiodine refractory differentiated thyroid cancer (RAIR-DTC). This phase II tri...
Keywords:
progressive radioiodine;
refractory differentiated;
differentiated thyroid;
thyroid cancer;
radioiodine refractory
Journal Title: Journal of Clinical Oncology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Clinical Oncology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!